2016
DOI: 10.1002/ccr3.570
|View full text |Cite
|
Sign up to set email alerts
|

Phacomatosis pigmentokeratotica or the Schimmelpenning‐Feuerstein‐Mims syndrome?

Abstract: Key Clinical MessageCutaneous symptoms in some patients with clinical picture of Schimmelpenning‐Feuerstein‐Mims syndrome can include a speckled lentiginous nevus, also known as nevus spilus. Recent investigations show that somatic heterozygous HRAS mutations are present in the sebaceous and speckled lentiginous nevus tissues of patients with combination of two nevi.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…Top-four PhiDsc predictions in HRAS were residues 12, 13, 74, and 93, which are known to be key functionals and often mutated in various cancer types (61). The domain comprising residues 12 and 13 is involved in Guanine Nucleotide Dissociation Inhibitor (GDI) interaction as well as interaction with GTP/Mg2+ (62), and is mostly detected in tumors such as bladder cancer (63), thyroid cancer(64), and other diseases such as Costello syndrome (61) and Schimmelpenning-Feuerstein-Mims syndrome (63, 65). Mutations in residue 74 are seen in endometrioid cancer and sebaceous carcinoma, while those in residue 93, have been discovered in only a small percentage of prostate cancer samples (66).…”
Section: Resultsmentioning
confidence: 99%
“…Top-four PhiDsc predictions in HRAS were residues 12, 13, 74, and 93, which are known to be key functionals and often mutated in various cancer types (61). The domain comprising residues 12 and 13 is involved in Guanine Nucleotide Dissociation Inhibitor (GDI) interaction as well as interaction with GTP/Mg2+ (62), and is mostly detected in tumors such as bladder cancer (63), thyroid cancer(64), and other diseases such as Costello syndrome (61) and Schimmelpenning-Feuerstein-Mims syndrome (63, 65). Mutations in residue 74 are seen in endometrioid cancer and sebaceous carcinoma, while those in residue 93, have been discovered in only a small percentage of prostate cancer samples (66).…”
Section: Resultsmentioning
confidence: 99%
“…The differential diagnoses are phacomatosis pigmentokeratotica, nevus comedonicus syndrome, and Proteus syndrome. 3 , 9 , 10…”
Section: Discussionmentioning
confidence: 99%
“…Variations in clinical phenotype and the degree of extracutaneous involvement are thought to be a result of the timing of the mutation during embryogenesis 2 . The majority of patients with PPK have extracutaneous involvement, most commonly ocular (strabismus and ptosis), neurologic (hemiparesis, hyperhidrosis, dysesthesia), and musculoskeletal (scoliosis, muscular weakness) abnormalities 4 . Approximately 30 cases of PPK have been reported in the literature, and fewer than 10 of these cases describe patients without extracutaneous involvement 5 …”
Section: Discussionmentioning
confidence: 99%